AstraZeneca Vaccine Is 79% Effective Against Symptomatic COVID-19, Company Says
AstraZeneca's COVID-19 vaccine showed 79% efficacy against symptomatic disease and 100% efficacy against severe disease and hospitalization in a new, US-based clinical trial, the company said Monday.